Methemoglobinemia differential diagnosis

Jump to navigation Jump to search

Methemoglobinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Methemoglobinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Methemoglobinemia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Methemoglobinemia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Methemoglobinemia differential diagnosis

on Methemoglobinemia differential diagnosis

Methemoglobinemia differential diagnosis in the news

Blogs on Methemoglobinemia differential diagnosis

Directions to Hospitals Treating Methemoglobinemia

Risk calculators and risk factors for Methemoglobinemia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Differential Diagnosis

Since the initial symptoms of methemoglobinemia can be equivocal, this condition can be easily misdiagnosed or even unrecognized. Symptoms correlate to the methemoglobin level and include skin and blood color changes at levels up to 15%. Neurologic and cardiac symptoms, as a result of hypoxia, are observed as levels rise above 15%. Levels higher than 70% are generally fatal.

Cyanosis that is unresponsive to oxygen treatment is the main physical finding in people with methemoglobinemia and it is due to different absorption spectrum of methemoglobin compared to normal hemoglobin. Apart from MetHb, cyanosis is also seen in people with increased levels of sulfhemoglobin, or in those undergoing treatment of MetHb with Methylene blue. Methylene blue can actually cause cyanotic discoloration to the skin, and this is important to know as it should not be perceived as a therapy failure. Cyanosis accompanied by hypoxia is usually caused by cardiac or pulmonary disease.


Differential Diagnoses

• Heart failure

• Pulmonary embolism

• Polycythemia

• Anemia

• Metabolic Acidosis

• Methylene blue treatment

• Sulfhemoglobin

• Asthma

• Anaphylaxis

References

Template:WS Template:WH